We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VitaFolks FemCare Vitality (previously VitaFolks OvaRaise Complete Ovarian Reproductive Support) (Icare Pharmaceuticals Pty Ltd)
Product Name
VitaFolks FemCare Vitality (previously VitaFolks OvaRaise Complete Ovarian Reproductive Support)
Sponsor
ARTG details
Date of review outcome
Date of publication
Sep-2025
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Seek advice from a suitably qualified health professional if you are intending on using this medicine for influencing the ovaries to support reproduction
Review scope
Targeted
Information reviewed
ARTG Record
Issues related to safety
The name of this medicine made claims regarding influencing the ovaries to support reproduction. These claims are not permitted for medicines that are available for self-selection without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to delay access to timely medical advice or treatment, which may result in adverse outcomes. However, as this medicine was never supplied in Australia with its former name, it is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The name of this medicine made claims regarding influencing the ovaries to support reproduction. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor updated the ARTG record to change the medicine name to 'VitaFolks FemCare Vitality'.